The worldwide e-commerce market is predicted to expand by 7.8% and reach a market value of $6.5 trillion by the end of this year. As an e-commerce operator, it is in your best interest to leverage the emerging trends so that your business can claim its fair share of this expanding market. We discuss some of those trends below.
Social Commerce
This is one big trend to watch if you are into e-commerce. Social media as well as other digital channels are the hallmarks in this trend. The concept allows transactions to happen easily between businesses and their target clientele. For example, social media platforms are being leveraged to promote products and enable sales to be concluded.
The key is to go where your customers are and engage them meaningfully. Remember that each platform is different, so customize the content you put out so that it fits into the overall tendencies within each platform. For example, TikTok is known for short videos, so don’t upload long-form text there!
Sustainability
Customers are increasingly paying attention to matters of sustainability and they expect the brands they patronize to do the same. Buyers won’t be content with companies doing the least just to be regarded as conscious of sustainability. Brands need to fully commit and make sustainability a core of their ethos.
So, invest in minimizing the carbon footprint of your e-commerce business by sourcing your inputs from suppliers implementing sustainability principles, ensure your website operates energy-efficiently and users don’t experience drag while visiting your site, among other changes.
Don’t Ignore Emerging Markets
Rather than struggling to get a foothold in a saturated market, why not consider targeting emerging markets where growth opportunities abound? Competition is likely to be less cutthroat and the growing numbers of people in the middleclass coupled with increasing access to high-speed internet gives businesses fertile conditions to thrive.
Utilize B2C Experiences
The younger demographic of B2B customers expect their transactions to be no different from the experiences that B2C clients enjoy. This includes personalization, dynamic pricing, exceptional search capabilities, among others.
You would be well advised to invest in making the B2B customer experience no different from what B2C experiences typically entail. Make the entire process from generating leads to closing a sale a single, seamless process.
Working with major players in the e-commerce space like NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) can give small firms access to the best technologies and platform to take their operations to the next level and increase the chances of thriving in this competitive industry.
NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL, NXPLW) are available in the company’s newsroom at https://ibn.fm/NXPL
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
A recent report published by the American Lung Association shows that only a tiny fraction…
Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the…
The company revealed the trial at the Australia Translational Breast Cancer Research Symposium (“ATBCR”) Sapu-003…
Approximately 20% of people in the U.S. live in a rural area, and they face…
On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant…
Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer.…